Physiological response to fluid resuscitation with Ringer lactate versus Plasmalyte in critically ill burn patients.


Journal

Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536

Informations de publication

Date de publication:
01 03 2020
Historique:
pubmed: 7 2 2020
medline: 24 6 2021
entrez: 7 2 2020
Statut: ppublish

Résumé

The metabolic consequences in vivo of various balanced solutions are poorly known in critically ill patients. The main objective of this study was to describe the metabolic consequences of Plasmalyte versus Ringer lactate (RL) in critically ill burn patients, with a special focus on the plasma clearance of buffer anions (i.e., gluconate, acetate, and lactate). We conducted a randomized trial between August 2017 and October 2018 in a tertiary teaching hospital in Paris, France. Patients with burn total body surface area >30% were randomized to receive Plasmalyte or RL. The primary end point was the base excess 24 h after inclusion. The secondary end points were acetate, gluconate, and lactate plasma concentration, the strong ion difference (SID). Twenty-eight patients were randomized. Twenty-four hours after inclusion, plasma BE was not significantly different in the Plasmalyte and RL groups {-0.9 [95% confidence interval (95% CI): -1.8-0.9] vs. -2.1 [95% CI: -4.6-0.6] mmol/L, respectively,

Identifiants

pubmed: 32027547
doi: 10.1152/japplphysiol.00859.2019
doi:

Substances chimiques

Gluconates 0
Isotonic Solutions 0
Ringer's Lactate 0
Lactic Acid 33X04XA5AT

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

709-714

Auteurs

Maïté Chaussard (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.

François Dépret (F)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.

Oriane Saint-Aubin (O)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.

Mourad Benyamina (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.

Maxime Coutrot (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.

Marion Jully (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.

Haikel Oueslati (H)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.

Alexandre Fratani (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.

Alexandru Cupaciu (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.

Alicia Poniard (A)

Laboratoire de Biochimie, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France.
Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), CNRS UMR8258-U1022, Faculté de Pharmacie Paris Descartes, Université de Paris, Paris, France.

Karim Asehnoune (K)

Service d'Anesthésie-Réanimation, Centre Hospitalier Universitaire de Nantes, Nantes, Pays De La Loire, France.

Solohaja-Faniaha Dimby (SF)

Unité de Recherche Clinique, AP-HP, Hôpital Fernand Widal, Statistique, Analyse et Modélisation Multidisciplinaire (SAMM) EA 4543, Université Paris 1 Panthéon Sorbonne, Paris, France.

Alexandre Mebazaa (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.

Pascal Houze (P)

Laboratoire de Biochimie, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France.
Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), CNRS UMR8258-U1022, Faculté de Pharmacie Paris Descartes, Université de Paris, Paris, France.

Matthieu Legrand (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hôpital (GH) Saint Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), French Clinical Research Infrastructure Network (F-CRIN), Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Paris, France.
Department of Anesthesiology and Perioperative Care, University of California San Francisco (UCSF) Medical Center, San Francisco, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH